Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Pyridine levels in ceftazidime - peritoneal dialysis admixtures stored at body temperature.

Nguyen TT, Harmanjeet H, Wanandy T, Castelino RL, Sud K, Jose MD, Peterson GM, Zaidi STR, Patel RP.

Perit Dial Int. 2020 Mar;40(2):171-178. doi: 10.1177/0896860819887636. Epub 2020 Jan 17.

PMID:
32063195
2.

Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions.

Harmanjeet H, Jani H, Zaidi STR, Wanandy T, Castelino RL, Sud K, Peterson GM, Patel RP.

Perit Dial Int. 2020 Feb 13:896860820902590. doi: 10.1177/0896860820902590. [Epub ahead of print]

PMID:
32052692
3.

Medication Adherence, Burden and Health-Related Quality of Life in Adults with Predialysis Chronic Kidney Disease: A Prospective Cohort Study.

Tesfaye WH, McKercher C, Peterson GM, Castelino RL, Jose M, Zaidi STR, Wimmer BC.

Int J Environ Res Public Health. 2020 Jan 6;17(1). pii: E371. doi: 10.3390/ijerph17010371.

4.

Anaesthetists' drug dosing practices in class III obese surgical patients: A bi-national survey.

Hussain Z, Gadd K, Curtain C, Mirkazemi C, Peterson GM, R Zaidi ST.

Anaesth Intensive Care. 2019 Nov;47(6):516-521. doi: 10.1177/0310057X19886596. Epub 2019 Nov 21. No abstract available.

PMID:
31752498
5.

Validation and Implementation of a National Survey to Assess Antimicrobial Stewardship Awareness, Practices and Perceptions amongst Community Pharmacists of Australia.

Rizvi T, Thompson A, Williams M, Zaidi STR.

J Glob Antimicrob Resist. 2019 Sep 7. pii: S2213-7165(19)30231-0. doi: 10.1016/j.jgar.2019.08.025. [Epub ahead of print]

6.

Chronic kidney disease monitoring in Australian general practice.

Khanam MA, Kitsos A, Stankovich J, Kinsman L, Wimmer B, Castelino R, Jose M, Zaidi STR, Radford J, M Peterson G.

Aust J Gen Pract. 2019 Mar;48(3):132-137. doi: 10.31128/AJGP-07-18-4630.

7.

Physical and chemical stability of ceftaroline in an elastomeric infusion device.

Al Madfai F, Zaidi STR, Ming LC, Wanandy T, Patel RP.

Eur J Hosp Pharm. 2018 Oct;25(e2):e115-e119. doi: 10.1136/ejhpharm-2017-001221. Epub 2017 Jul 24.

8.

Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions.

Khaleel I, Zaidi STR, Shastri MD, Eapen MS, Ming LC, Wanandy T, Patel RP.

Eur J Hosp Pharm. 2018 Oct;25(e2):e102-e108. doi: 10.1136/ejhpharm-2017-001225. Epub 2017 Jul 19.

9.

Physicochemical stability of voriconazole in elastomeric devices.

Harmanjeet H, Zaidi STR, Ming LC, Wanandy T, Patel RP.

Eur J Hosp Pharm. 2018 Oct;25(e2):e88-e92. doi: 10.1136/ejhpharm-2016-001170. Epub 2017 Apr 10.

10.

Health Literacy Studies Conducted in Australia: A Scoping Review.

Choudhry FR, Ming LC, Munawar K, Zaidi STR, Patel RP, Khan TM, Elmer S.

Int J Environ Res Public Health. 2019 Mar 28;16(7). pii: E1112. doi: 10.3390/ijerph16071112.

11.

Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease.

Tesfaye WH, Peterson GM, Castelino RL, McKercher C, Jose M, Zaidi STR, Wimmer BC.

J Clin Med. 2019 Mar 21;8(3). pii: E395. doi: 10.3390/jcm8030395.

12.

Adherence assessment practices in haemodialysis settings: A qualitative exploration of nurses and pharmacists' perspectives.

Ghimire S, Lee K, Jose MD, Castelino RL, Zaidi STR.

J Clin Nurs. 2019 Jun;28(11-12):2197-2205. doi: 10.1111/jocn.14821. Epub 2019 Mar 12.

PMID:
30786082
13.

The effect of hospitalization on potentially inappropriate medication use in older adults with chronic kidney disease.

Tesfaye WH, Wimmer BC, Peterson GM, Castelino RL, Jose MD, McKercher C, Zaidi STR.

Curr Med Res Opin. 2019 Jun;35(6):1119-1126. doi: 10.1080/03007995.2018.1560193. Epub 2019 Jan 11.

PMID:
30557066
14.

Prophylactic Cefazolin Dosing and Surgical Site Infections: Does the Dose Matter in Obese Patients?

Hussain Z, Curtain C, Mirkazemi C, Gadd K, Peterson GM, Zaidi STR.

Obes Surg. 2019 Jan;29(1):159-165. doi: 10.1007/s11695-018-3497-0.

15.

Medication adherence assessment practices in dialysis settings: A survey of renal nurses' perceptions.

Ghimire S, Banks C, Jose MD, Castelino RL, Zaidi STR.

J Clin Nurs. 2019 Feb;28(3-4):528-537. doi: 10.1111/jocn.14642. Epub 2018 Aug 28.

PMID:
30091498
16.

Medication Regimen Complexity and Hospital Readmission in Older Adults With Chronic Kidney Disease.

Tesfaye WH, Peterson GM, Castelino RL, McKercher C, Jose MD, Wimmer BC, Zaidi STR.

Ann Pharmacother. 2019 Jan;53(1):28-34. doi: 10.1177/1060028018793419. Epub 2018 Aug 2.

PMID:
30070583
17.

Stability of Meropenem and Piperacillin/Tazobactam with Heparin in Various Peritoneal Dialysis Solutions.

Mendes K, Harmanjeet H, Sedeeq M, Modi A, Wanandy T, Zaidi STR, Ming LC, Castelino RL, Sud K, Peterson GM, Patel RP.

Perit Dial Int. 2018 Nov-Dec;38(6):430-440. doi: 10.3747/pdi.2017.00274. Epub 2018 Jul 10.

PMID:
29991562
18.

Therapeutic Potential of Enoxaparin in Lichen Planus: Exploring Reasons for Inconsistent Reports.

Patel RP, Shastri MD, Ming LC, Zaidi STR, Peterson GM.

Front Pharmacol. 2018 Jun 5;9:586. doi: 10.3389/fphar.2018.00586. eCollection 2018. Review.

19.

Australian Community Pharmacists' Experience of Implementing a Chronic Kidney Disease Risk Assessment Service.

Gheewala PA, Peterson GM, Zaidi STR, Jose MD, Castelino RL.

Prev Chronic Dis. 2018 Jun 14;15:E81. doi: 10.5888/pcd15.170485.

20.

Stability of milrinone in continuous ambulatory delivery devices.

Madfai FA, Zaidi STR, Ming LC, Wanandy T, Patel RP.

Am J Health Syst Pharm. 2018 May 1;75(9):e241-e245. doi: 10.2146/ajhp170372.

PMID:
29691268

Supplemental Content

Loading ...
Support Center